None listed
Conditions
Brief summary
The primary purpose of the study is evaluate the efficacy of azitromycin (a drug) in infants less than 7 months of age with acute viral bronchiolitis, by reducing the length of hospital stay.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Infants less than 7 months of age who were admitted to Hospital de Clínicas de Porto Alegre between March 2009 and July 2010 with a first episode of wheezing requiring hospitalization and supplemental oxygen, with a clinical diagnosis of bronchiolitis
Exclusion criteria
Infants with cardiac, metabolic disease or clinically significant respiratory disease, such as cystic fibrosis, were not eligible, although infants with chronic neonatal lung disease associated with prematurity were included. Infants were excluded if they had received corticosteroids in any form within 7days before presentation or had received macrolides before presentation.